Envoy Medical Inc. (COCH) - Net Assets
Based on the latest financial reports, Envoy Medical Inc. (COCH) has net assets worth $3.30 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($23.95 Million) and total liabilities ($20.65 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See net asset quality index of Envoy Medical Inc. to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.30 Million |
| % of Total Assets | 13.79% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Envoy Medical Inc. - Net Assets Trend (2020–2025)
This chart illustrates how Envoy Medical Inc.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Envoy Medical Inc. stock valuation.
Annual Net Assets for Envoy Medical Inc. (2020–2025)
The table below shows the annual net assets of Envoy Medical Inc. from 2020 to 2025. Also explore net asset momentum of Envoy Medical Inc. to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-11.77 Million | +37.55% |
| 2024-12-31 | $-18.84 Million | -960.92% |
| 2023-12-31 | $-1.78 Million | +95.09% |
| 2022-12-31 | $-36.20 Million | +19.50% |
| 2021-12-31 | $-44.96 Million | -185128.19% |
| 2020-12-31 | $24.30K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Envoy Medical Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 31339529900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.00K | % |
| Other Comprehensive Income | $-120.00K | % |
| Other Components | $301.75 Million | % |
| Total Equity | $-11.77 Million | 100.00% |
Envoy Medical Inc. Competitors by Market Cap
The table below lists competitors of Envoy Medical Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Roundtop Machinery Industries Co Ltd
TW:1540
|
$52.51 Million |
|
Coxon Precise Industrial Co Ltd
TW:3607
|
$52.51 Million |
|
GAMEVIL Inc
KQ:063080
|
$52.52 Million |
|
AmanahRaya Real Estate Investment Trust
KLSE:5127
|
$52.53 Million |
|
SuperCom Ltd
F:50S
|
$52.50 Million |
|
eXoZymes, Inc.
NASDAQ:EXOZ
|
$52.48 Million |
|
KENERGY
KLSE:0307
|
$52.47 Million |
|
Brimag -L
TA:BRMG
|
$52.47 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Envoy Medical Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -18,842,000 to -11,767,000, a change of 7,075,000.
- Net loss of 23,756,000 reduced equity.
- Dividend payments of 1,819,000 reduced retained earnings.
- Share repurchases of 184,000 reduced equity.
- New share issuances of 7,098,000 increased equity.
- Other comprehensive income increased equity by 3,000.
- Other factors increased equity by 25,733,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-23.76 Million | -201.89% |
| Dividends Paid | $1.82 Million | -15.46% |
| Share Repurchases | $184.00K | -1.56% |
| Share Issuances | $7.10 Million | +60.32% |
| Other Comprehensive Income | $3.00K | +0.03% |
| Other Changes | $25.73 Million | +218.69% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Envoy Medical Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.00 | $0.68 | x |
| 2021-12-31 | $-4.43 | $0.68 | x |
| 2022-12-31 | $-3.56 | $0.68 | x |
| 2023-12-31 | $-0.14 | $0.68 | x |
| 2024-12-31 | $-1.00 | $0.68 | x |
| 2025-12-31 | $-0.51 | $0.68 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Envoy Medical Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9857.26%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-0.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -2.88% | 0.00% | 0.00x | 4.94x | $-3.13K |
| 2021 | 0.00% | -2798.39% | 0.12x | 0.00x | $-4.18 Million |
| 2022 | 0.00% | -6718.57% | 0.09x | 0.00x | $-12.30 Million |
| 2023 | 0.00% | -9468.99% | 0.04x | 0.00x | $-29.74 Million |
| 2024 | 0.00% | -9242.22% | 0.02x | 0.00x | $-18.91 Million |
| 2025 | 0.00% | -9857.26% | 0.03x | 0.00x | $-22.58 Million |
Industry Comparison
This section compares Envoy Medical Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $638,670,729
- Average return on equity (ROE) among peers: -85.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Envoy Medical Inc. (COCH) | $3.30 Million | -2.88% | 6.25x | $52.51 Million |
| Abbott Laboratories (ABT) | $4.40 Billion | 38.41% | 1.14x | $177.76 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $11.55 Million |
| Aethlon Medical Inc (AEMD) | $-9.30 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-131.82 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $780.04 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $1.53 Million | -361.86% | 1.36x | $4.88 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $1.19 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.16 Million |
| Artivion Inc (AORT) | $79.80 Million | -34.79% | 0.33x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $127.64 Million |
About Envoy Medical Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseoin… Read more